ANO1 and cystic fibrosis: Dysfunction of TMEM16A has been implicated in a number of diseases such as hypercontractility in asthmatic airways and hypertensive blood vessels13,14, while enhancing TMEM16A activity may improve epithelial function in cystic fibrosis and other mucoobstructive diseases15–18.